Stocks
Denali Therapeutics (DNLI) ROE US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| ROE, % | ? | -30.2% | -31.3% | -14.1% | -34.4% | -50.6% | -54.9% | |
| Changes by years, y/y, % | -36pp | -1pp | +17pp | -20pp | -16pp | |||
Denali Therapeutics. ROE, %
Denali Therapeutics. ROE, changes, pp
Denali Therapeutics (DNLI) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -40.4% | -46.6% | -53.8% | -50.6% | -54.9% | -54.9% | |
| Changes by years, y/y, % | -31pp | -16pp | -21pp | -16pp | -14pp | |||
| Changes by quarters, q/q, % | -6pp | -6pp | -7pp | +3pp | -4pp | |||
